# TRIM60

## Overview
TRIM60 is a gene that encodes the protein tripartite motif containing 60, which is a member of the tripartite motif (TRIM) protein family. This protein is characterized by a RING zinc finger domain, a B-box 2 domain, coiled-coil segments, and a B30.2 domain, which collectively contribute to its function as an E3 ubiquitin and SUMO ligase. TRIM60 plays a crucial role in modulating immune responses by acting as a negative regulator of the TLR4/TLR9 signaling pathways, thereby inhibiting the activation of MAPK and NF-κB pathways. It is primarily expressed in the testis and is involved in interactions with cytoplasmic motor proteins, suggesting a role in testicular functions. Additionally, TRIM60 has been implicated in various diseases, including cancer, where it influences immune and inflammatory pathways (Huang2011Association; Gao2022Pancancer; Gu2020The).

## Structure
TRIM60, also known as RNF33, is a protein characterized by a tripartite motif (TRIM) structure, which includes a RING zinc finger domain, a B-box 2 domain, two alpha-helical coiled-coil segments, and a B30.2 domain. The RING domain is crucial for its E3 ubiquitin ligase activity, facilitating ubiquitination processes. The B30.2 domain acts as a protein-interacting module, essential for interactions with target proteins (Huang2011Association).

The coiled-coil domain of TRIM60 is involved in modulating structural conformation, which is important for its interactions with other proteins, such as the kinesin motor proteins KIF3A and KIF3B. These interactions are mediated by specific domains: the B30.2 domain interacts with the rod domain of KIF3A, while the RB domain interacts with the rod-tail domain of KIF3B (Huang2011Association).

TRIM60 is also implicated in post-translational modifications, such as SUMOylation, where it acts as an E3 SUMO ligase. This modification is significant in regulating the TLR signaling pathway by interacting with TAB2, thereby inhibiting NF-κB activation (Gu2020The). The protein is expressed specifically in the testis, with a cytoplasmic localization pattern (Huang2011Association).

## Function
TRIM60, a member of the tripartite motif (TRIM) protein family, plays a significant role in regulating the innate immune response. It functions as a negative regulator of the TLR4/TLR9 signaling pathways by mediating the SUMOylation of TAB2, a process that inhibits the activation of MAPK and NF-κB pathways. This SUMOylation occurs at specific lysine residues on TAB2, preventing the formation of the TRAF6/TAB2/TAK1 complex and thereby dampening downstream signaling pathways (Gu2020The).

TRIM60 is primarily active in the cytoplasm, where it interacts with various proteins to modulate immune signaling pathways. Its RING domain is essential for its function as an E3 SUMO ligase, facilitating the SUMOylation of TAB2. This interaction is crucial for maintaining immune homeostasis by suppressing excessive inflammatory responses (Gu2020The).

In addition to its role in immune regulation, TRIM60 is expressed in the testis, where it interacts with cytoplasmic motor proteins KIF3A and KIF3B. These interactions suggest a potential role in the kinesin-dependent mobilization of specific cargos, contributing to testicular functions (Huang2011Association).

## Clinical Significance
TRIM60 has been implicated in various diseases and conditions due to its role in regulating immune responses and cellular signaling pathways. Alterations in TRIM60 expression or function can significantly impact immune response regulation, potentially affecting susceptibility to infections and inflammatory conditions. TRIM60 acts as a negative regulator of the TLR4/TLR9 signaling pathways, and its deficiency leads to enhanced activation of MAPK and NF-κB pathways, resulting in increased production of proinflammatory cytokines. This dysregulation can contribute to heightened immune responses, as observed in TRIM60-deficient mice, which exhibit increased susceptibility to LPS-induced septic shock and resistance to Listeria monocytogenes infection (Gu2020The).

In the context of cancer, TRIM60, along with other TRIM proteins, is implicated in regulating innate immune and inflammatory pathways. Mutations in TRIM genes, including TRIM60, are common in tumors and can influence gene expression, impacting cancer and immune-related pathways. These mutations are associated with immune checkpoints and immune cell infiltrations, which can affect cancer progression and response to immune therapies (Gao2022Pancancer). The evolutionary dynamics of TRIM60, characterized by rapid evolution and species-specific adaptations, suggest its potential involvement in species-specific immune responses and disease susceptibility (Sardiello2008Genomic).

## Interactions
TRIM60, also known as RNF33, is involved in several protein interactions that play significant roles in cellular processes. It interacts with the cytoplasmic motor proteins KIF3A and KIF3B, which are part of the kinesin-2 family. These interactions occur independently of the kinesin-associated protein KAP3, suggesting that TRIM60 forms a distinct complex with KIF3A and KIF3B. The interaction domains have been mapped, showing that the B30.2 domain of TRIM60 is crucial for its interaction with the rod domain of KIF3A, while the RB domain of TRIM60 primarily interacts with the rod-tail domain of KIF3B (Huang2011Association).

TRIM60 also plays a role in immune signaling pathways by interacting with TAB2, a component of the TAK1 signalosome. It acts as an E3 SUMO ligase, mediating the SUMOylation of TAB2, which inhibits the MAPK and NF-κB signaling pathways. This interaction is crucial for regulating the innate immune response, as it suppresses the formation of the TRAF6/TAB2/TAK1 complex, thereby reducing proinflammatory cytokine production. The SPRY domain of TRIM60 is essential for binding to TAB2, and the RING domain is necessary for the SUMOylation process (Gu2020The).


## References


[1. (Gu2020The) Zhiwen Gu, Xueying Chen, Wenyong Yang, Yu Qi, Hui Yu, Xiaomeng Wang, Yanqiu Gong, Qianqian Chen, Bo Zhong, Lunzhi Dai, Shiqian Qi, Zhiqiang Zhang, Huiyuan Zhang, and Hongbo Hu. The sumoylation of tab2 mediated by trim60 inhibits mapk/nf-κb activation and the innate immune response. Cellular &amp; Molecular Immunology, 18(8):1981–1994, November 2020. URL: http://dx.doi.org/10.1038/s41423-020-00564-w, doi:10.1038/s41423-020-00564-w. This article has 11 citations.](https://doi.org/10.1038/s41423-020-00564-w)

[2. (Huang2011Association) Chiu-Jung Huang, Chih-Cheng Huang, and Chih-Chun Chang. Association of the testis-specific trim/rbcc protein rnf33/trim60 with the cytoplasmic motor proteins kif3a and kif3b. Molecular and Cellular Biochemistry, 360(1–2):121–131, September 2011. URL: http://dx.doi.org/10.1007/s11010-011-1050-8, doi:10.1007/s11010-011-1050-8. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-011-1050-8)

[3. (Sardiello2008Genomic) Marco Sardiello, Stefano Cairo, Bianca Fontanella, Andrea Ballabio, and Germana Meroni. Genomic analysis of the trim family reveals two groups of genes with distinct evolutionary properties. BMC Evolutionary Biology, August 2008. URL: http://dx.doi.org/10.1186/1471-2148-8-225, doi:10.1186/1471-2148-8-225. This article has 220 citations.](https://doi.org/10.1186/1471-2148-8-225)

[4. (Gao2022Pancancer) Yueying Gao, Tao Pan, Gang Xu, Si Li, Jing Guo, Ya Zhang, Qi Xu, Jiwei Pan, Yanlin Ma, Juan Xu, and Yongsheng Li. Pan-cancer illumination of trim gene family reveals immunology regulation and potential therapeutic implications. Human Genomics, December 2022. URL: http://dx.doi.org/10.1186/s40246-022-00441-9, doi:10.1186/s40246-022-00441-9. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-022-00441-9)